These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15531279)

  • 21. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?
    Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G
    Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrating economic analysis into clinical trials.
    Imai K; Zhang P
    Lancet; 2005 May 21-27; 365(9473):1749-50. PubMed ID: 15910936
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 26. Low high-density lipoprotein cholesterol and response to simvastatin therapy in Scandinavian Simvastatin Survival Study (4S).
    Robins S
    Circulation; 2002 Jul; 106(2):e8; author reply e8. PubMed ID: 12105176
    [No Abstract]   [Full Text] [Related]  

  • 27. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
    [No Abstract]   [Full Text] [Related]  

  • 29. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
    Scheen AJ; Radermecker RP
    Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin: two decades in a circle.
    Kolovou GD; Katerina A; Ioannis V; Cokkinos DV
    Cardiovasc Ther; 2008; 26(2):166-78. PubMed ID: 18485137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foundations for blockbuster drugs in federally sponsored research.
    Thompson RB
    FASEB J; 2001 Aug; 15(10):1671-6. PubMed ID: 11481212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
    Endo A; Kuroda M; Tanzawa K
    Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding indications of statins; implications of the Heart Protection Study.
    Salam AM
    Expert Opin Investig Drugs; 2003 Mar; 12(3):509-13. PubMed ID: 12605572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
    Pedersen TR; Olsson AG; Faergeman O; Kjekshus J; Wedel H; Berg K; Wilhelmsen L; Haghfelt T; Thorgeirsson G; Pyörälä K; Miettinen T; Christophersen B; Tobert JA; Musliner TA; Cook TJ;
    Atheroscler Suppl; 2004 Oct; 5(3):99-106. PubMed ID: 15531282
    [No Abstract]   [Full Text] [Related]  

  • 37. Scandinavian simvastatin study (4S).
    Manzato E
    Lancet; 1994 Dec 24-31; 344(8939-8940):1767; author reply 1767-8. PubMed ID: 7997016
    [No Abstract]   [Full Text] [Related]  

  • 38. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 39. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
    Virani SS; Akeroyd JM; Nambi V; Maddox TM; Gillette MA; Michael Ho P; Rumsfeld J; Petersen LA; Ballantyne CM
    Am J Med; 2015 Nov; 128(11):1253-6. PubMed ID: 26071828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terje Rolf Pedersen, MD: a conversation with the editor. Interview by William Clifford Roberts.
    Pedersen TR
    Am J Cardiol; 1999 Nov; 84(10):1234-45. PubMed ID: 10569335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.